The Investigational Cancer Therapeutics Fellowship at MD Anderson Cancer Center provides intensive training in early-phase clinical trials, personalized oncology, and novel drug development. Fellows gain expertise in designing, conducting, and analyzing first-in-human and translational studies, preparing them for impactful careers in academia, industry, or government.
Eligibility Criteria:
-
M.D. or D.O. degree required.
-
Completion of a Hematology/Oncology fellowship or equivalent advanced training.
-
Demonstrated interest in drug development and early-phase clinical research.
-
Successful completion of USMLE Steps 1 and 2.
-
Foreign-trained physicians must have valid ECFMG certification.
Funding Details:
-
Fellowship duration: 1, 2, or 3 years.
-
Fellows gain direct experience developing and conducting early-phase clinical and translational trials.
-
MD Anderson’s environment offers access to over 1,250 active clinical trials and leading experts across oncology research disciplines.
Deadline:
Applications are accepted on a rolling basis; prospective fellows are encouraged to inquire early to align with upcoming start dates.
Where To Go For Further Information:
- Program details.
- Contact: [email protected].